Christian Rados
Willing to Win
Biotech Leaders Against All OddsBiotech leaders, founders and executives are warriors chasing cures against impossible odds. Their journeys are not only about science, but about belief, resilience, and leadership. Willing to Win is the podcast where these stories are told - the late nights, the rejections, the doubts, and the unshakable conviction that keeps them going. Each episode gives listeners an intimate look into the emotional “why” behind biotech leaders, offering inspiration, connection, and lessons in leadership and perseverance that apply far beyond biotech.
Be sure to visit the podcast's website and support the creator: podcasters.spotify.com
Author
Christian Rados
Category
Podcast website
Latest episode
Nov 12, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Episode 24 | What Most Biotech Leaders Get Wrong About Psychological Safety (Caroline Schober) 12.11.2026 1:04:43
Caroline Schober once worked with a company whose CEO was the superhero of every story he told. He didn't want bad news, so his people stopped bringing it, and the real problems only came up after the meetings. Caroline was Vice-Rector for Research and International Affairs at MedUni Graz for eight years. With Christian Rados she talks about psychological safety and her one-sentence test for i...
The moment you start to doubt yourself is the moment you should stop - Sezai Taskin 01.10.2026 31:57
"The moment you start to doubt yourself is the moment you should stop." Sezai Taskin says that after two years of investor no's, two of them one signature away. A few days before this episode went live, his company ViferaXS closed a Series A of up to 12 million euros, led by SPRIND and Huma. This episode is about the space between those two sentences: what a no does to your confidenc...
Episode 22 | So, Do We Have a Deal? (Achim Plum, HTGF) 17.09.2026 52:07
Achim Plum spent 25 years on the operator side of biotech. Two IPOs, one of them closed on the last day of the roadshow, sitting at a Zurich breakfast with no idea whether the book would fill by evening. His last company died on the science itself. He says: "I did every possible mistake one could do. I survived them mostly." Then he switched sides. Since January 2025 he runs HTGF, German...
Episode 21 | I Shouldn't Be Here: Moderna's First CSO on Making Life Count (Antonin de Fougerolles) 10.09.2026 53:48
Tony de Fougerolles was born in Montreal three months premature, weighing about a pound and a half. He was the youngest child in Canada to survive at that age and weight. Twenty years of operations followed: doctors two or three times a week, surgery every summer, every Christmas. Ask him what he would change, and he says: nothing. "I shouldn't be here. This is all extra, let's make t...
Episode 20 | I Can't Not Be Fascinated (Wolfgang Hofmann) 03.09.2026 40:17
As a child, Wolfgang Hofmann was more often sick in bed than in school, his asthma so severe that a doctor told his parents he would probably not survive. Ask him about it today, and he gives you one sentence on resilience. Then he talks about curiosity. That is the pattern of this whole conversation. The engine of his career is not the illness. It is fascination, and the people who passed it on:...
Episode 19 | We understand only 8 % of Biology (Karol Jarzabek) 28.08.2026 1:00:31
Eight percent of drugs make it to approval. Karol Jarzabek thinks that is roughly how much we understand about biology as a civilization, and he thinks the real number is lower. He also thinks he knows why. The best minds in the field spend three quarters of their time at a bench, and most of that work is work they have already done once. This is a conversation about what a person does with a numb...
Episode 18 | Turning down the obvious path (Rosario "Charo" Cestau Murphy) 13.08.2026 20:52
Halfway through her career, Rosario "Charo" Cestau Murphy did the thing nobody advises. She left a global role in Boston and moved to Latin America for a job that was smaller on paper. Her own words for the move: "I call this going from the Pentagon to the trenches." In this episode, Christian Rados sits down with Charo for a conversation about the decisions that do not show up...
Episode 17 | The fight for thousands is not over (Dr. Dominik Witzigmann) 30.07.2026 51:58
Three years ago, Dr. Dominik Witzigmann wrote on LinkedIn: "Last month, we lost the battle against lymphoblastic leukemia. But the fight for thousands of others is not over." He was writing about his daughter, Lotta, who passed away at close to four years old, just eight weeks after her first symptoms. In this episode of WILLING TO WIN, Christian Rados sits down with Dominik for one of t...
Episode 16 | Why This CRISPR Founder Built a Biotech Without VC Money (Tilmann Burckstummer) 21.07.2026 40:53
Tilmann Bürckstümmer co-founded Myllia Biotechnology in Vienna in 2018 and never raised venture capital. Not because he couldn't. Because the money would have cost more than it was worth. The reasoning is specific. A VC needs a 10x or 20x return, and in biotech that return only exists if you develop a drug and get it to market. Myllia is a technology company. Build a technology company on VC m...
The Truth About Biotech Funding Nobody Wants To Admit (Jan de Kerpel) 28.05.2026 46:32
Fifteen percent of biotech deals took half the capital in 2025. A senior banker explains who got it and why. Jan De Kerpel runs life sciencesand healthcare investment banking at Van Lanschot Kempen. Before that he was a scientist, working on an HIV drug that is still saving lives today. He moved from the lab to the trading floor by accident, and he has stayed there for twodecades because, he says...
FemTech's Trillion-Dollar Question Nobody Asked (Simone Sabbione -Meliodays) 21.05.2026 52:30
Period pain isn't normal. Medicine made it normal. For decades, severe menstrual pain has been dismissed as something women should accept, normalize, or medicate away with the pill. Meanwhile, an entire market and an entire patient population has been ignored by mainstream biotech. In this episode of Willing to Win , Christian Rados sits down with Simone Sabbione, co-founder of Meliodays, the Muni...
From Shakespeare to a Biotech Exit (Chris Przybyszewski) 19.05.2026 55:24
Chris Przybyszewski raised over $150 million, founded five companies, and was fired four times. He also studied literature and founded a theatre before biotech. In this episode of Willing to Win, he gives the unedited account of taking US Biologic from a Lyme disease vaccine to a near-acquisition, with a poultry program and a chewable human flu vaccine in the pipeline. Willing to Win is the biotec...
What Nobody Told Me About Resilience — A CFO's Hard Warning (Miguel Coego Rios) 07.05.2026 34:12
Miguel Coego Rios has spent 20 years leading through the toughest environments in European pharma. Restructurings. Turnarounds. Investor pressure. From the outside, he looked unbreakable. He wasn't. In this episode Miguel does something most senior leaders never do - he talks openly about the moment resilience stopped being a strength and became a trap. Medication. Anxiety. Six months of recov...
Sabotaged and Still Building | Klaus Weinberger 23.04.2026 46:00
Klaus Weinberger co-invented one of the first real-time PCR assays used in diagnostic labs across Europe. He never patented it. He never made a dime. That was just the beginning. What followed was three decades of building in life science diagnostics. A sabotaged patient database. A toxic board member who cost two years of runway. A company sold after nine years with deeply mixed feelings. A fundi...
Femtech, Trust & Venture Capital - Inside Real Investment Decisions | Melissa Simon & Christian Rados 09.04.2026 45:49
What do investors actually look for in founders when the stakes are real? In this episode, Melissa Simon (Wieland Capital) shares how investment decisions are made in life sciences and healthcare beyond the pitch, beyond the story. We talk about what builds trust during due diligence, why realism matters more than conviction, and what it actually means to commit capital when outcomes are uncertain...
The Biggest Pain as a Leader? 40 Years of Hard Truths in Biotech (Pierre Morgon) 02.04.2026 44:35
Dr. Pierre Morgon has fired good people and been fired himself. Twice. After 40 years and countless board seats in biotech, pharma, and vaccines, he shares what nobody tells you about leading in life sciences. In this conversation with Christian Rados he talks about why comfort is "horribly sedative" in big pharma, what founders get wrong about IPOs, the boss who told him to never love t...
Every Chapter Needs a Different You - The Cost of Not Transforming (Peter Seufer-Wasserthal) 19.03.2026 36:28
Episode 8 of Willing To Win Every Chapter Needs a Different You - The Cost of Not Transforming with Peter Seufer-Wasserthal Peter Seufer - Wasserthal didn't have one career. He had eight. Each chapter demanded a version of himself that didn't exist yet. PhD chemist. Business developer. Remote operator from anAustrian village before the internet. The outsider who outperformed the insider. The g...
How The Biotech Game Breaks Your Idealism - A Drug Hunter's Confession (Zoltan Magyarics) 12.03.2026 30:12
Willing to Win - Biotech Leaders Against All Odds Episode 7 Every scientist who enters drug development believes the science will find its way. That if the biology is right, the path forward is clear. That conviction is enough. Zoltan Magyarics believed it too. Then the phase two failed. The lead program died. And the belief that great science finds its own way broke with it. In this episode of Wi...
What Nobody Tells You About a Life-Changing Deal (Erich Tauber) 05.03.2026 37:44
What Nobody Tells You About a Life-Changing Deal (Erich Tauber) Episode 6 13 years of building. Never funded for more than 12 months. Hundreds of investors who said this will never work. Then a life-changing deal with Merck, signed in the middle of a pandemic, thirty minutes after telling the notary it was fifty-fifty. But the hardest part wasn't the struggle. It was what came after. In this e...
Winning The Infinite Game - Why Great Leaders Embrace Failure (Ilkka Haukijärvi) 26.02.2026 27:26
If you take real risks as a leader, failure is guaranteed. The only question is when. Most executives try to avoid failure. Great leaders prepare for it. In Episode 5 of Willing To Win Biotech Leaders Against All Odds, Christian Rados sits down with Ilkka Haukijärvi to explore what Winning means. Ilkka made a radical domain jump. From Director of HR at a Finnish university to CEO building a global...
Ownership Of The Downside | Elite Leaders Under Pressure (Jesper Brandgaard) 19.02.2026 40:08
Willing To Win: Biotech Leaders Against All Odds Episode 4 Ownership Of The Downside | Elite Leaders Under Pressure (Jesper Brandgaard) What separates elite leaders from the rest? In this episode of Willing To Win, Christian Rados sits down with Jesper Brandgaard to unpack a leadership principle most executives underestimate: If you want authority, you must own the downside. Jesper Brandgaard is C...
An IPO Is Just The Beginning | The Real Fight Starts When You Go Public (Oliver Schacht) 12.02.2026 46:46
Willing To Win: Biotech Leaders Against All Odds Episode 3 An IPO Is Just the Beginning | The Real Fight Starts When You Go Public (Oliver Schacht) In this episode of Willing To Win , Christian Rados sits down with Oliver Schacht to unpack a truth most founders only discover the hard way: The IPO is not the victory. It is the moment the real pressure begins. Oliver Schacht is a PhD-trained molecul...
Feeling Out Of Place | The Story Behind Edwin Moses - And How Insecurity Fueled Optimism (Edwin Moses) 05.02.2026 42:05
Willing To Win: Biotech Leaders Against All Odds Episode 2 Feeling Out Of Place | The Story Behind Edwin Moses - And How Insecurity Fueled Optimism In this episode of Willing to Win , Christian Rados sits down with Edwin Moses , one of the most accomplished and quietly influential leaders in European biotech, to explore the inner journey behind a lifetime of exceptional outcomes. Edwin Moses has p...
Leaving Ego Aside | Inside the CureVac–BioNTech Deal 29.01.2026 41:57
Episode 1 of Willing to Win . In the opening episode of Willing to Win , Christian Rados speaks with Thaminda Ramanayake about leadership when ego must be set aside and decisions are made without certainty. When Thaminda joined CureVac, the company was under intense pressure. The stock was in free fall, the equity story relied heavily on litigation, and confidence in the European mRNA ecosystem wa...
Willing To Win - Official Trailer (Season 1) - Start January 29, 2026 16.01.2026 1:19
Willing to Win is a podcast about leadership in biotech when there are no easy answers. In conversations with founders, CEOs, and senior executives, the focus is on what no one prepares you for:making decisions under uncertainty,carrying responsibility without a safety net,and leading through pressure, doubt, and consequences that don’t disappear. At its core, Willing to Win is about conviction ag...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.